Views & Analysis Clinical trials: realising the untapped potential Winning proposal to create a corporate social responsibility (CSR) programme.
Articles Clinical trials insight: oncology INC Research's Dr Nick Kenny talks about the challenges of running global clinical trials in the rapidly evolving field of oncology.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.